Schober, Tilmann
Morris, Shaun K.
Bettinger, Julie A.
Burton, Catherine
Halperin, Scott A.
Jadavji, Taj
Kazmi, Kescha
Modler, Jacqueline
Sadarangani, Manish
Papenburg, Jesse
Foo, Cheryl
Bridger, Natalie
Top, Karina
Thibeault, Roseline
Lebel, Marc
Le Saux, Nicole
Bullard, Jared
Purewal, Rupeena
Sauvé, Laura
,
Funding for this research was provided by:
Public Health Agency of Canada
Article History
Received: 12 September 2023
Accepted: 22 October 2023
First Online: 6 November 2023
Declarations
:
: Dr. Papenburg reports grants from MedImmune, grants and personal fees from Merck, personal fees from AstraZeneca, all outside the submitted work. Dr. Sadarangani has been an investigator on projects funded by GlaxoSmithKline, Merck, Moderna, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. Dr. Halperin has been an investigator on projects funded by Sanofi-Pasteur, GlaxoSmithKline and Seqirus. Dr. Morris is a coinvestigator on an investigator-led grant from Pfizer, has served on an ad-hoc advisory boards for Pfizer, Sanofi Pasteur, and Merck and has received speaker fees from GlaxoSmithKline and JNJ China; all unrelated to this study. The other authors have no conflicts of interest to disclose.